SCHEMBL7236265

SCHEMBL7236265

Clc1cc2nc(Cl)c(-c3ccccn3)nc2cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.59
NPC1 O15118 3/20 0.59
METAP1 P53582 4/20 0.49
CCR1 P32246 3/20 0.49
CCR5 P51681 3/20 0.49
CCR8 P51685 3/20 0.49
LMNA P02545 2/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
BLM P54132 1/20 0.43
HIF1A Q16665 1/20 0.43
DOHH Q9BU89 1/20 0.43
P4HTM Q9NXG6 1/20 0.43
CBFB Q13951 2/20 0.43
TP53 P04637 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPK1 P28482 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ALPL P05186 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7952022 0.91 KDM4E (0.70) KDM4ENPC1METAP1CCR1CCR5
SCHEMBL21941944 0.87 METAP1 (0.57) KDM4ENPC1METAP1CCR1CCR5
SCHEMBL7237961 0.83 KDM4E (0.55) KDM4ENPC1METAP1CCR1CCR5
SCHEMBL7235358 0.83 KDM4E (0.51) KDM4ENPC1METAP1CCR1CCR5
SCHEMBL7965339 0.79 KDM4E (0.81) KDM4ENPC1METAP1CCR1CCR5
SCHEMBL7963689 0.76 KDM4E (0.75) KDM4ENPC1METAP1CCR1CCR5
SCHEMBL21174606 0.75 METAP1 (0.47) KDM4ENPC1METAP1CCR1CCR5
SCHEMBL4075083 0.74 KDM4E (1.00) KDM4ENPC1METAP1CCR1CCR5
SCHEMBL6305952 0.74 KDM4E (0.74) KDM4ENPC1LMNASMN1; SMN2TDP1
SCHEMBL21941951 0.73 METAP1 (0.50) KDM4ENPC1METAP1CCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6548499-B1 N-(1-Azabicyclo(2.2.2)octanyl-3-pyridinyl)-3-(2-pyridinyl)-2 -quinoxalinamine, for example; treating various chemokine mediated diseases MILLENNIUM PHARMACEUTICALS, INC. 2003-04-15 US disclosed
WO-1999042463-A1 SUBSTITUTED QUINOXALINE DERIVATIVES AS INTERLEUKIN-8 RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-08-26 WO disclosed